Article

Identification of Blood-based Biomarkers for Early Stage Parkinson’s Disease

2020-10-27

Abstract excerpt

Parkinson’s disease (PD) affects millions of people worldwide and causes symptoms such as bradykinesia and disrupted speech. Parkinson’s disease is known to be characterized by the mass death of dopaminergic neurons in the substantia nigra region. In the status quo, PD is often diagnosed at late stages because obvious motor symptoms appear after the disease has progressed far. It is advantageous to diagnose PD bef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3deced4b-68ec-52c7-ba2a-75836082b4e6
DOI: 10.1101/2020.10.22.20217893

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Blood-based Biomarkers for Early Stage Parkinson’s DiseaseDOI 10.1101/2020.10.22.20217893Read

Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s diseaseSemantic proximity Read

Integrative Analysis of Gene Expression Profiles of Substantia Nigra Identifies Potential Diagnosis Biomarkers in Parkinson's diseaseSemantic proximity Read

miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s diseaseSemantic proximity Read

Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's diseaseSemantic proximity Read

Differential gene expression and immune profiling in Parkinson’s disease: unveiling potential candidate biomarkersSemantic proximity Read

Identification of Significant Immune Related Genes and Pathways in Parkinson’s disease via Bioinformatics Analysis of Single-Cell RNA Sequencing DataSemantic proximity Read

Identification of potential diagnostic biomarkers for Parkinson's diseaseSemantic proximity Read

Identification of Novel Noninvasive Diagnostics Biomarkers in the Parkinson’s Diseases and Improving the Disease Classification Using Support Vector MachineSemantic proximity Read

Identification of Hub Genes And Potential Molecular Mechanisms In Peripheral Blood Mononuclear Cells of Patients With Parkinson’s DiseaseSemantic proximity Read

Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics AnalysisSemantic proximity Read

A molecular signature in blood identifies early Parkinson's disease.Semantic proximity Read

A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson’s diseaseSemantic proximity Read